BridgeBio Pharma reports Q3 loss of $56.7 million, beating expectations
BBIO BridgeBio Pharma Inc
$78.67 +0.95%
View chart & analysis → - 1BridgeBio Pharma Inc. reported a loss of $56.7 million in the third quarter.
- 2BridgeBio Pharma Inc. recorded a loss of 42 cents per share in the third quarter.
- 3BridgeBio Pharma Inc. achieved revenue of $353.2 million during the period.
So what's the key point?
BridgeBio Pharma Inc. recorded a loss of $56.7 million in the third quarter. This means the loss was larger than what experts had expected.
Source Associated Press +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.